At a glance
- Originator Bristol-Myers Squibb
- Class Antineoplastics; Benzoic acids; Retinoids
- Mechanism of Action Retinoic acid receptor alpha antagonists; Retinoic acid receptor beta agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Skin disorders